FH
Last Updated: Sep 01, 2016
- Exploring Gaps of Family History Documentation in EHR for Precision Medicine -A Case Study of Familial Hypercholesterolemia Ascertainment.
Mehrabi Saeed et al. AMIA Joint Summits on Translational Science proceedings. AMIA Summit on Translational Science 2016 2016160-6 - The Prevalence and Prognostic Importance of Possible Familial Hypercholesterolemia in Patients with Myocardial Infarction
S Rerup et al, AM Heart Journal, August 2016 - Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano Paula et al. JAMA 2016 Aug 316(6) 645-55 - Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
et al. JAMA 2016 Aug 316(6) 625-33 - Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
Kazi Dhruv S et al. JAMA 2016 Aug 316(7) 743-753 - Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
DS Kazi et al, JAMA August 16, 2016 - Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla Leopoldo et al. Journal of the American College of Cardiology 2016 Mar 67(11) 1278-85 - Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia- Evidence Report and Systematic Review for the US Preventive Services Task Force
P Lozano et al, JAMA, August 9, 2016 - Why Cholesterol Testing in Children and Adolescents Matters
SS Gidding. JAMA Cardiology, August 9, 2016 - Screening for Lipid Disorders in Children and Adolescents US Preventive Services Task Force Recommendation Statement
USPSTF, JAMA, August 9, 2016 - What’s on the Horizon for HoFH Treatment
The FH Foundation, August 2, 2016 - Screening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?
Disease: Familial Hypercholesterolemia; Type: Data|Program; State: Multiple States - Clinical familial hypercholesterolaemia: high lipoprotein(a) and LPA risk genotypes as possible risk factors
Lancet Diabetes & Endocrinology, July 25, 2016 - Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
Modell Stephen M et al. Healthcare (Basel, Switzerland) 2016 4(1) - Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
Besseling Joost et al. Journal of the American College of Cardiology 2016 Jul 68(3) 252-60
- Human (59)
- Pathogen (0)
- Human (251)
- Pathogen (0)
- Human (53)
- Pathogen (0)
- Huamn (52)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario